
SHP-77 - CRL-2195 | ATCC
The SHP-77 (Shadyside Hospital, Pittsburgh, PA) cell line is a biochemically stable continuously cultured cell line which has retained important features of SCLC.
SHP-77. Culture Collections
SHP-77 express neural cell adhesion molecule (NCAM), NHK-1, CD56 and the cell surface leucocyte antigen Leu-7 (HNK-1;CD57). Other neuroendocrine markers are L-dopa …
Cellosaurus cell line SHP-77 (CVCL_1693)
Stability and utility of the unique human small cell carcinoma line SHP-77. Human tumor lines for cancer research. Feasibility of drug screening with panels of human tumor cell lines using a …
Stability and Utility of the Unique Human Small Cell Carcinoma Line SHP-77
Jun 1, 1985 · SHP-77 can serve as an in vitro target in 51 Cr and 111 In release cytotoxicity assays as well as in in vivo nude mouse assays for evaluating immune reactivity of cells and …
SHP-77 - 南模生物
SHP-77 epithelial cells are derived from a non-encapsulated primary lung tumor from the apical portion of the upper lobe of the left lung of a 54-year-old, White male in 1977.
SHP-77 cell line is human small cell lung carcinoma (SCLC) epithelial cell line established in 1977. SHP-77 expresses neural cell adhesion molecule (NCAM), NHK-1, CD56, and the cell …
SHP-77 | Cell - PubChem
Jan 5, 2022 · Cell information for SHP-77. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.
98110201, human lung, Not specified | Sigma-Aldrich
Human Caucasian lung small cell carcinoma, large cell variant. SHP-77 was established in 1977 being derived from a non-encapsulated primary lung tumor from the apical portion of the upper …
SHP-77 cell line|AcceGen
The SHP-77 cell line finds valuable applications in various research contexts. It serves as an in vitro target for 51 Cr and 111 In release cytotoxicity assays, facilitating the study of cytotoxic …
OncoWuXi Express: Efficacy of DLL3 CAR-T in SHP-77 Tumor Models
We have conducted efficacy evaluations in cell line-derived small-cell lung cancer SHP-77-Luc in murine subcutaneous and orthotopic tumor models with DLL3 CAR-T therapy.